Healio: Percutaneous ventricular assist devices yield similar periprocedural outcomes in high-risk PCI Supira Medical announced today that it received FDA approval to initiate a new trial of its percutaneous ventricular assist device (pVAD). CNW/ -- (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assist device (pVAD) market, ... EurekAlert!: Novel percutaneous ventricular assist device feasibile in patients undergoing high-risk percutaneous coronary interventions (HRPCI) Phoenix, AZ, () - Findings from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD) were presented today as late-breaking clinical research at the Society for ...
Novel percutaneous ventricular assist device feasibile in patients undergoing high-risk percutaneous coronary interventions (HRPCI) Medical Xpress: Successful cardiogenic shock treatment using a percutaneous left ventricular assist device FOX40 News: SUPIRA MEDICAL ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS NEXT GENERATION PERCUTANEOUS VENTRICULAR ASSIST DEVICE SUPIRA MEDICAL ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS NEXT GENERATION PERCUTANEOUS VENTRICULAR ASSIST DEVICE Please provide your email address to receive an email when new articles are posted on . Use of a novel low-profile, high continuous flow percutaneous ventricular assist device was feasible in six high ... Business Wire: Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device Cardiovascular Systems, Inc.
percutaneous ventricular assist device, Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Enginprime Medical Inc ("Enginprime"), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a Voyagers Capital portfolio ... Please provide your email address to receive an email when new articles are posted on . A new meta-analysis highlights similar periprocedural outcomes between two percutaneous ventricular assist ... MassDevice: Supira gets FDA green light to conduct ventricular assist device study
